# US 4,399,129 A · Treating shock

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 4,399,129 A
- Document ID: US4399129A
- Status: Granted
- Kind: A
- Application number: 06/343,627
- Filed: 1982-01-28
- Granted: 1983-08-16
- Earliest claimed: 1981-02-12
- Assignees: John Wyeth & Brother Limited
- Inventors: Elizabeth Gowers; Martin H. Todd
- Web page: https://patentgrep.com/patent/US4399129A

## CPC

- A61K 31/55: having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/02: Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Meptazinol and its pharmaceutically acceptable acid addition salts can be used in treating shock in mammals.

## Claims

### Claim 1

A method of treating shock in mammals which comprises administering to a mammal suffering from shock an effective amount of meptazinol or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

A method according to claim 1 wherein the mammal is suffering from haemorrhagic, endotoxic or anaphylactic shock.

### Claim 3 (depends on 1, 2)

A method according to claim 1 or claim 2 wherein the compound administered is meptazinol hydrochloride.